세계의 첨단 치료제 의약품 아웃소싱 시장 보고서(2025년)

Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

첨단 치료제 의약품 아웃소싱 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 이 기간 동안의 성장은 바이오 제약 인프라의 성장, 규제 준수, 만성 및 생명을 위협하는 질병 치료를 위한 신약에 대한 수요 증가, 효율성 향상, 개인 맞춤형 의약품에 대한 수요 증가에 기인합니다. 예측 기간의 주요 동향으로는 기술 진보, 첨단 치료법의 전문 지식 향상, 혁신적인 치료법의 파이프라인 증가, 최첨단 기술의 통합, 유전자 치료, 세포 치료, mRNA 기술의 급속한 진보 등을 들 수 있습니다.

세포요법과 유전자요법의 채용 증가가 예상되기 때문에 향후 수년간은 첨단 치료제 의약품 아웃소싱 시장의 확대가 전망될 예정입니다. 첨단 치료제 의약품 아웃소싱은 입증된 제공업체와 경험이 풍부한 인재에 대한 액세스를 허가함으로써 세포 및 유전자 치료를 지원하는 중요한 역할을 수행합니다. 이 전략적 접근 방식을 통해 기업은 내부 팀을 만드는 데 소요되는 시간과 자원을 절약할 수 있습니다. 특히 영국의 과학 저널인 Nature의 보고서에 따르면 유전자 치료로 치료를 받는 신규 환자 수가 2020년 16,244명에서 2025년 94,696명으로 크게 증가할 것으로 예상되어 첨단 치료제 의약품 아웃소싱 시장의 성장 원동력이 더욱 확고해졌습니다.

첨단 치료제 의약품 아웃소싱 시장의 유력 기업은 서비스 제공을 강화하고 고객의 요구에 효과적으로 대응하기 위해 전략적 파트너십을 적극적으로 추진하고 있습니다. 위의 사업체(통상은 기업)간의 협력적인 약정을 특징으로 하고, 각 파트너가 단독으로 달성하기 어려운, 상호 유익한 목표를 달성하는 것을 목적으로 하고 있습니다. 예를 들면, 2023년 1월, 스위스에 본사를 두고 제약, 생명공학, 영양분야에 서비스를 제공하는 제조업체인 론자는 고형암 치료제의 개발을 전문으로 하는 미국의 바이오의약품회사인 컨텍스트 세라퓨틱스사와 협업했습니다. 이 제휴를 통해 론자는 제조 가능성 평가, 유전자·세포주 구축, 원약·제제의 프로세스 개발 등의 주요 서비스를 제공하여 컨텍스트·세라퓨틱스사의 대처를 지원합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 첨단 치료제 의약품 아웃소싱 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 성장률 분석
• 세계의 첨단 치료제 의약품 아웃소싱 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 첨단 치료제 의약품 아웃소싱 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 첨단 치료제 의약품 아웃소싱 전체 시장(TAM)

제6장 시장 세분화

• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 서비스 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 임상시험수탁기관(CRO)
• 위탁 개발 및 제조 기관(CDMO)
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 적응증별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 종양학
• 신경학
• 심장학
• 감염성 질환
• 기타 적응증
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 치료별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세포 치료
• 유전자 치료
• RNA 기반 치료
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 용도별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 전임상 서비스
• 임상 서비스
• 상업용 제조 및 포장
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 임상시험수탁기관(CRO) 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 전임상 연구 서비스
• 임상시험 관리 서비스
• 규제 업무 서비스
• 데이터 관리 및 생물통계학
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 위탁 개발 및 제조 기관(CDMO) 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 의약품 개발 서비스
• 제형 개발
• 분석 테스트 서비스
• 상업용 제조 서비스

제7장 지역별/국가별 분석

• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 지역별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 첨단 치료제 의약품 아웃소싱 시장 : 국가별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 첨단 치료제 의약품 아웃소싱 시장 : 경쟁 구도
• 첨단 치료제 의약품 아웃소싱 시장 : 기업 프로파일
  • Thermo Fisher Scientific Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Laboratory Corporation of America Holdings 개요, 제품 및 서비스, 전략 및 재무 분석
  • IQVIA 개요, 제품 및 서비스, 전략 및 재무 분석
  • ICON plc 개요, 제품 및 서비스, 전략 및 재무 분석
  • SGS SA 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Lonza Group
• Parexel International Corporation
• WuXi AppTec
• Syneos Health
• Catalent Inc.
• Charles River Laboratories International
• Recipharm AB
• Croda International Plc
• Samsung Biologics
• Vetter Pharma International GmbH
• Medpace Holdings Inc.
• Fujifilm Diosynth Biotechnologies
• Marken
• AGC Biologics
• Evotec SE

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 첨단 치료제 의약품 아웃소싱 시장(2029년) : 새로운 기회를 제공하는 국가
• 첨단 치료제 의약품 아웃소싱 시장(2029년) : 새로운 기회를 제공하는 부문
• 첨단 치료제 의약품 아웃소싱 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

KTH

영문 목차

영문목차

Advanced Therapeutic Pharmaceutical Outsourcing involves the delegation of specialized pharmaceutical services related to advanced therapeutic products. These products typically encompass advanced therapies such as cell and gene therapies, personalized medicines, biologics, and other innovative treatments. The outsourcing of these services is undertaken to leverage specialized expertise and capabilities in the production, testing, and development of advanced therapeutic products.

The primary services within advanced therapeutics pharmaceutical outsourcing include Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs). CROs and CDMOs offer a range of specialized services to support the development and commercialization of advanced therapeutic products. These services cater to various medical fields, including oncology, neurology, cardiology, infectious diseases, and others. Outsourcing activities may involve services related to cell therapy, gene therapy, and RNA-based therapies, covering preclinical services, clinical services, as well as commercial manufacturing and packaging applications.

The advanced therapeutics pharmaceutical outsourcing market research report is one of a series of new reports from The Business Research Company that provides advanced therapeutics pharmaceutical outsourcing market statistics, including advanced therapeutics pharmaceutical outsourcing industry global market size, regional shares, competitors with an advanced therapeutics pharmaceutical outsourcing market share, detailed advanced therapeutics pharmaceutical outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the advanced therapeutics pharmaceutical outsourcing industry. This advanced therapeutics pharmaceutical outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The advanced therapeutics pharmaceutical outsourcing market size has grown steadily in recent years. It will grow from $8.07 billion in 2024 to $8.43 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to growth in biopharmaceutical infrastructure, regulatory compliance, increasing demand for novel drugs to treat chronic and life-threatening diseases, improved efficiency, and growing demand for personalized medicine.

The advanced therapeutics pharmaceutical outsourcing market size is expected to see strong growth in the next few years. It will grow to $10.27 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the increasing adoption of cell and gene therapies, The increasing focus on mRNA therapies, rising demand for cutting-edge treatments, improved efficiency and cost-effective solutions provided by outsourcing partners, and collaborative innovation. Major trends in the forecast period include technological advancement, rising expertise in advanced therapeutics, escalating pipeline of innovative therapies, the integration of cutting-edge technology, rapid advancements in gene therapy, cell therapy, and mRNA technologies.

The anticipated increase in the adoption of cell and gene therapies is set to drive the expansion of the advanced therapeutics pharmaceutical outsourcing market in the coming years. Cell and gene therapies, representing innovative treatments that leverage living cells or genetic material to address and cure diseases, have gained prominence in the medical landscape. Advanced therapeutics pharmaceutical outsourcing plays a crucial role in supporting cell and gene therapies by granting access to established providers with a proven track record and experienced personnel. This strategic approach allows companies to save both time and resources that would otherwise be spent on building in-house teams. Notably, a report by Nature, a UK-based scientific journal, projected a significant rise in the number of new patients treated with gene therapies, from 16,244 in 2020 to an estimated 94,696 in 2025, further affirming the driving force behind the growth of the advanced therapeutics pharmaceutical outsourcing market.

Prominent companies in the advanced therapeutics pharmaceutical outsourcing market are actively pursuing strategic partnerships to enhance their service offerings and cater to the needs of their customers effectively. A strategic partnership, characterized by a collaborative arrangement between two or more entities, typically businesses, aims to achieve mutually beneficial goals that may be challenging for each partner to accomplish independently. For instance, in January 2023, Lonza, a Switzerland-based manufacturing company serving the pharmaceutical, biotechnology, and nutrition sectors, entered into a partnership with Context Therapeutics Inc., a US-based biopharmaceutical company specializing in advancing medicines for solid tumors. This collaboration involves Lonza providing key services such as manufacturability assessment, gene and cell line construction, and process development for both drug substance and drug product in support of Context Therapeutics' initiatives.

In August 2022, Catalent Inc., a pharmaceutical company headquartered in the United States, completed the acquisition of Metrics Contract Services and Contract Development and Manufacturing Organization (CDMO) for a total of $475 million. This strategic acquisition is poised to enhance Catalent's expertise in integrated oral solid formulation development, manufacturing, and packaging, thereby enabling customers to streamline and expedite their programs. Additionally, the acquisition will broaden Catalent's capacity to manage highly potent compounds. Metrics Contract Services and Contract Development and Manufacturing Organization (CDMO), a US-based provider offering specialized services for drug development and manufacturing, was identified as a key asset to reinforce Catalent's position in the pharmaceutical industry.

Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics

North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the advanced therapeutics pharmaceutical outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The advanced therapeutics pharmaceutical outsourcing market includes revenues earned by entities by providing services such as research and development support, process development and manufacturing, comprehensive analytical testing and characterization, regulatory support, clinical manufacturing, commercial manufacturing, implementation of quality systems, consulting and strategic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on advanced therapeutics pharmaceutical outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for advanced therapeutics pharmaceutical outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced therapeutics pharmaceutical outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service Type: Contract Research Organizations (CROs); Contract Development And Manufacturing Organizations (CDMOs)
• 2) By Indication: Oncology; Neurology; Cardiology; Infectious Diseases; Other Indications
• 3) By Therapy: Cell Therapy; Gene Therapy; RNA-based Therapies
• 4) By Application: Preclinical Services; Clinical Services; Commercial Manufacturing And Packaging
• Subsegments:
• 1) By Contract Research Organizations (CROs): Preclinical Research Services; Clinical Trial Management Services; Regulatory Affairs Services; Data Management And Biostatistics
• 2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services; Formulation Development; Analytical Testing Services; Commercial Manufacturing Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; IQVIA; ICON plc; SGS SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Advanced Therapeutics Pharmaceutical Outsourcing Market Characteristics

3. Advanced Therapeutics Pharmaceutical Outsourcing Market Trends And Strategies

4. Advanced Therapeutics Pharmaceutical Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Advanced Therapeutics Pharmaceutical Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Advanced Therapeutics Pharmaceutical Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Rate Analysis
• 5.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Advanced Therapeutics Pharmaceutical Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Advanced Therapeutics Pharmaceutical Outsourcing Total Addressable Market (TAM)

6. Advanced Therapeutics Pharmaceutical Outsourcing Market Segmentation

• 6.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Research Organizations (CROs)
• Contract Development And Manufacturing Organizations (CDMOs)
• 6.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Other Indications
• 6.3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Therapy
• Gene Therapy
• RNA-based Therapies
• 6.4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Services
• Clinical Services
• Commercial Manufacturing And Packaging
• 6.5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Sub-Segmentation Of Contract Research Organizations (CROs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Research Services
• Clinical Trial Management Services
• Regulatory Affairs Services
• Data Management And Biostatistics
• 6.6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Sub-Segmentation Of Contract Development And Manufacturing Organizations (CDMOs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Development Services
• Formulation Development
• Analytical Testing Services
• Commercial Manufacturing Services

7. Advanced Therapeutics Pharmaceutical Outsourcing Market Regional And Country Analysis

• 7.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market

• 8.1. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Advanced Therapeutics Pharmaceutical Outsourcing Market

• 9.1. China Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 9.2. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Advanced Therapeutics Pharmaceutical Outsourcing Market

• 10.1. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market

• 11.1. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 11.2. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market

• 12.1. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market

• 13.1. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market

• 14.1. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 14.2. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market

• 15.1. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 15.2. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Advanced Therapeutics Pharmaceutical Outsourcing Market

• 16.1. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market

• 17.1. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Advanced Therapeutics Pharmaceutical Outsourcing Market

• 18.1. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market

• 19.1. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market

• 20.1. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market

• 21.1. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 21.2. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market

• 22.1. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Advanced Therapeutics Pharmaceutical Outsourcing Market

• 23.1. North America Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 23.2. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Advanced Therapeutics Pharmaceutical Outsourcing Market

• 24.1. USA Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 24.2. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market

• 25.1. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 25.2. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Advanced Therapeutics Pharmaceutical Outsourcing Market

• 26.1. South America Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 26.2. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market

• 27.1. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market

• 28.1. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 28.2. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market

• 29.1. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
• 29.2. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Advanced Therapeutics Pharmaceutical Outsourcing Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Landscape
• 30.2. Advanced Therapeutics Pharmaceutical Outsourcing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. IQVIA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. ICON plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

31. Advanced Therapeutics Pharmaceutical Outsourcing Market Other Major And Innovative Companies

• 31.1. Lonza Group
• 31.2. Parexel International Corporation
• 31.3. WuXi AppTec
• 31.4. Syneos Health
• 31.5. Catalent Inc.
• 31.6. Charles River Laboratories International
• 31.7. Recipharm AB
• 31.8. Croda International Plc
• 31.9. Samsung Biologics
• 31.10. Vetter Pharma International GmbH
• 31.11. Medpace Holdings Inc.
• 31.12. Fujifilm Diosynth Biotechnologies
• 31.13. Marken
• 31.14. AGC Biologics
• 31.15. Evotec SE

32. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Advanced Therapeutics Pharmaceutical Outsourcing Market

34. Recent Developments In The Advanced Therapeutics Pharmaceutical Outsourcing Market

35. Advanced Therapeutics Pharmaceutical Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Advanced Therapeutics Pharmaceutical Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료